Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

SKYEPHARMA PLC (SKP)

12
Delayed Quote. Delayed London Stock Exchange - 01/28 11:35:10 am
259.75 GBp   +0.10%
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
2014 SKYEPHARMA : Launches Flutiform In Spain, Italy; New Product In Japa..
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/22/2015 01/23/2015 01/26/2015 01/27/2015 01/28/2015 Date
259.75(c) 258.25(c) 251(c) 259.5(c) 259.75 Last
232 923 240 464 122 101 495 088 153 812 Volume
+0.68% -0.58% -2.81% +3.39% +0.10% Change
More quotes
Company
SkyePharma Plc is a UK based pharmaceutical company.It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products.The company approves products in the areas of oral, inhalation and topical delivery.SkyePharma was founded by... 
Sector
Pharmaceuticals
Calendar
03/19Earnings Release
More about the company
Surperformance© ratings of SkyePharma PLC
Trading Rating : Investor Rating :
More Ratings
Chart SKYEPHARMA PLC
Duration : Period :
SkyePharma PLC Technical Analysis Chart | SKP | GB00B3BFNB64 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 75,7 M
EBIT 2014 22,0 M
Net income 2014 -0,16 M
Finance 2014 15,1 M
Yield 2014 -
Sales 2015 97,3 M
EBIT 2015 25,8 M
Net income 2015 24,8 M
Finance 2015 34,3 M
Yield 2015 -
PER 2014 -
PER 2015 10,64
EV / Sales 2014 3,39x
EV / Sales 2015 2,44x
Capitalization 272 M
More Financials
Latest news on SKYEPHARMA PLC
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
2014 SKYEPHARMA : Launches Flutiform In Spain, Italy; New Product In Japan
2014 SKYEPHARMA : Says Sales Momentum Has Continued Since August
2014 SKYEPHARMA : Partner Announces Phase III Flutiform Study Results
2014 SKYEPHARMA : announces Interim Results 2014
2014 SKYEPHARMA : Holding(s) in Company
2014 SKYEPHARMA : Reports Interim Results Statement
More news
Sector news Pharmaceuticals - NEC
12:49p US markets plunge after top firms post poor results
12:46pDJEU Approves Three-Part Deal Between Novartis, GlaxoSmithKline
12:33p GLAXOSMITHKLINE : EU Approves Novartis-Glaxo Business Swap, With Concessions
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF